Clinical Trial Update: Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm [Phase 3]

View source ↗

Summary

Phase 3 trial of acetaminophen for aneurysmal subarachnoid hemorrhage to inhibit lipid peroxidation and cerebral vasospasm was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Cerebral Vasospasm

Drugs mentioned

• Acetaminophen (Acetaminophen)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Aneurysmal Subarachnoid Hemorrhage, Cerebral Vasospasm | Phase 3 | Status: TERMINATED | Results posted: 2025-04-18